InvestorsHub Logo
Followers 35
Posts 7658
Boards Moderated 0
Alias Born 01/18/2012

Re: stpioc post# 14237

Monday, 05/08/2017 1:16:24 PM

Monday, May 08, 2017 1:16:24 PM

Post# of 15276
You have to be Steve, I'd bet on it.

Late stage biotech companies, even with similar market caps, often have considerable institutional investment, DSNY has none, zero, end of a really inapt comparison.

Oops, jee willikers, we released Clipstream 2 and then, gollee, we ran into throttling problems. Why the heck didn't they test the thing before Steve went around the country selling it at investor conferences (I saw him twice)? But, gee, we'll really try better this time! You honestly believe anyone else considers this a legitimate excuse?

Ok, conspiracy time: the money from MPE goes into Clipstream development. How much of that is spend on "administrative costs" and whose pocket does that money go into. We don't know, do we, there's not exactly any transparency.

Questions: why is MPE revenue so much less than it was in 2014 and 2015 and why does DSNY make it so hard to read the revenue charts on its own website?

No one, and I mean no one, is buying your shtick, you have yet to receive a single positive comment on your many attempts at revisionist history. You like this stock, fine, buy more (it is at almost a 10 year low, after all) and good luck.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DSNY News